|
English
|
正體中文
|
简体中文
|
0
|
|
???header.visitor??? :
52771106
???header.onlineuser??? :
635
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"wang hp"???jsp.browse.items-by-author.description???
Showing items 171-195 of 255 (11 Page(s) Totally)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
View [10|25|50] records per page
| 臺北醫學大學 |
2000 |
D-Phenylglycine-L-dopa as slow-release prodrug of dopamine.
|
王惠珀; Wang HP |
| 臺北醫學大學 |
1999 |
Drug Delivery Through Dipeptide Transporter (I): Anti-Parkinsonism Effect of D-Phenylglycine-L-dopa and L-Dopa-D-Phenylglycine after Oral Administration.
|
王惠珀; Wang HP |
| 臺北醫學大學 |
1999 |
Aminoacyl Antraquinones as potential antineoplastic agents.
|
王惠珀; Lee O; LeeLT; Wu HS; Wang HP |
| 臺北醫學大學 |
1999 |
Selective cytotoxicity of novel Azatyrosinamides.
|
王惠珀; Lee O; Li YI; Hwang CF; Wang HP |
| 臺北醫學大學 |
1999 |
b-Azatyrosinamides: Synthesis and Selective cytotoxicity
|
王惠珀; Lee O; Wang HP |
| 臺北醫學大學 |
1999 |
Synthesis and inhibition of pyrimidine analogues on bovine liver dihydrofolate redutase.
|
王惠珀; Lee O; Wu HS; Liu WC; Wang HP |
| 臺北醫學大學 |
1999 |
Drug Delivery Through Dipeptide Transporter (II): CNS Bioavailability of D-Phenylglycine-L-dopa in Rats.
|
王惠珀; Lee SN; Wang HP |
| 臺北醫學大學 |
1999 |
Intestinal Oligopeptide Transporter (PepT1) as a Drug Delivery System: D-Phenylglycine as a Seeing-eye Dog for L-Dopa Transport through PepT1.
|
王惠珀; Wang HP |
| 臺北醫學大學 |
1999 |
Selective cytotoxicity of novel Azatyrosinamides.
|
王惠珀; Lee O; Li YI; Hwang CF; Wang HP |
| 臺北醫學大學 |
1999 |
Synthesis and inhibition of pyrimidine analogues on bovine liver dihydrofolate redutase.
|
王惠珀; Lee O; Wu HS; Liu WC; Wang HP |
| 臺北醫學大學 |
1999 |
Drug Delivery Through Dipeptide Transporter (III): Species Differences between Rats and Rabbits in the Pharmacokinetics of D-Phenylglycine-L-dopa.
|
王惠珀; Luo WW; Fan YB; Wang HP; |
| 臺北醫學大學 |
1999 |
Drug Delivery Through Dipeptide Transporter (II): Species Differences between Rats and Rabbits in the Pharmacokinetics of D-Phenylglycine-L-dopa.
|
王惠珀; Luo WW; Fan YB; Wang HP; |
| 臺北醫學大學 |
1999 |
Intestinal Oligopeptide Transporter (PepT1) as a Drug Delivery System: D-Phenylglycine as a Seeing-eye Dog for L-Dopa Transport through PepT1.
|
王惠珀; Wang HP |
| 臺北醫學大學 |
1999 |
Primary sclerosing cholangitis in a child.
|
朱娟秀; Lin WT; Lin SJ; Ni YH; Chen HL; Wang HP; Chu JS; Chang MH; |
| 臺北醫學大學 |
1998 |
Methods in the Preparation of D-Phenylglycine-containing Cefotaxime Double Esters (Cefotaxime-PG).
|
王惠珀; Sun CH; Wang HP |
| 國立臺灣大學 |
1998 |
Helicobacter pylori infection and age on the development of intestinal metaplasia: a multiple logistic regression analysis
|
Wang, CC; Wu, MS; Wang, HH; Wang, HP; Lee, WC; Shun, CT; Lin, JT |
| 國立臺灣大學 |
1998 |
Gastric cancer risk in relation to Helicobacter pylori infection and subtypes of intestinal metaplasia
|
Wu, MS; Shun, CT; Lee, WC; Chen, CJ; Wang, HP; Lee, WJ; Sheu, JC; Lin, JT |
| 國立臺灣大學 |
1998 |
Overexpression of p53 in different subtypes of intestinal metaplasia and gastric cancer
|
Wu, MS; Shun, CT; Lee, WC; Chen, CJ; Wang, HP; Lee, WJ; Sheu, JC; Lin, JT |
| 臺北醫學大學 |
1997 |
Inhibition of azatyrosine analogues on the growth of Ras-transformed tumor cells.
|
王惠珀; Lee O; Shu CY; Lee SJ; Wang HP |
| 臺北醫學大學 |
1997 |
2-Amino-4-methyl-5-(4-substituted-1-piperazinyl) pyrimidin-6-ones, preparation and Use.
|
王惠珀; Wang HP; Bai TS |
| 臺北醫學大學 |
1997 |
Novel Di and Tripeptide Mimetic Compounds for Parkinson Disease.
|
王惠珀; Wang HP; Lee JS; Tsai MC; Lu HH; Hu OYP; Lo WL |
| 臺北醫學大學 |
1997 |
Electrophilic Condensation of Pyrimidines with Cyclic Ketones.
|
王惠珀; Lee O; Wang HP |
| 臺北醫學大學 |
1997 |
Medical Education Evaluation
|
王惠珀; Wang HP |
| 臺北醫學大學 |
1997 |
Preparation of D-Phenylglycinyl Derivatives of Cefuroxime as Double Ester Prodrugs.
|
王惠珀; Lee JS; Sun CH; Wang HP; |
| 臺北醫學大學 |
1997 |
Synthesis and Stability Studies on a Tripartite Prodrug of Cefuroxime.
|
王惠珀; Lee JS; Koo SW; Lui IH; Wang HP |
Showing items 171-195 of 255 (11 Page(s) Totally)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
View [10|25|50] records per page
|
